Huang, Min <br/><br/>
Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.  [electronic resource] 

 -  Experimental gerontology  05 2017 
 - 25-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-6815 
<br/><br/><label>Standard No.: </label>10.1016/j.exger.2017.02.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid Precursor Protein Secretases--metabolism<br/>Amyloid beta-Peptides--metabolism<br/>Animals<br/>Aspartic Acid Endopeptidases--metabolism<br/>Autophagy--drug effects<br/>Berberine--pharmacology<br/>Brain--pathology<br/>Cognitive Dysfunction--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Maze Learning--drug effects<br/>Memory--drug effects<br/>Mice<br/>Mice, Transgenic<br/>Neurons--metabolism<br/>Neuroprotective Agents--pharmacology<br/>Plaque, Amyloid--metabolism